Skip to main content
. 2017 Jan 5;8(7):11302–11315. doi: 10.18632/oncotarget.14513

Figure 7. Antibody to mortalin inhibits exosome secretion from MCF-7 breast cancer cells.

Figure 7

MCF-7 cells were either transfected with antibodies to mortalin or alpha-tubulin, or treated with SMRwt or SMRmut peptides. (A) Relative exosome release level after 48 hr by AchE assay. (B) Relative numbers of exosomes released after 48 hr by NanoSight analysis. Error bars represent the mean ± SD of three independent experiments. Significant differences relative to untreated cells: *p < 0.0001, **p < 0.0001.